Use of Yttrium-90 Radioembolization for Management of Colorectal Liver Metastases
- 20 August 2016
- journal article
- research article
- Published by Springer Nature in Current Colorectal Cancer Reports
- Vol. 12 (5) , 226-231
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Prognostic factors and prevention of radioembolization-induced liver diseaseHepatology, 2012
- Yttrium-90 Radioembolization as Salvage Therapy for Colorectal Cancer With Liver MetastasesClinical Colorectal Cancer, 2012
- Patient Selection and Activity Planning Guide for Selective Internal Radiotherapy With Yttrium-90 Resin MicrospheresInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage PatientsJournal of Vascular and Interventional Radiology, 2012
- Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesBritish Journal of Cancer, 2010
- Liver metastases from colorectal cancer: radioembolization with systemic therapyNature Reviews Clinical Oncology, 2009
- Posttherapy Radiation Safety Considerations in Radiomicrosphere Treatment with 90Y-MicrospheresJournal of Nuclear Medicine, 2007
- Improving Long-Term Outcomes for Patients With Liver Metastases From Colorectal CancerJournal of Clinical Oncology, 2005
- Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysisBMJ, 2000
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993